278 related articles for article (PubMed ID: 33769276)
21. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
22. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.
Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123
[TBL] [Abstract][Full Text] [Related]
23. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
[TBL] [Abstract][Full Text] [Related]
25. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
26. An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease.
Koganebuchi K; Sato K; Fujii K; Kumabe T; Haneji K; Toma T; Ishida H; Joh K; Soejima H; Mano S; Ogawa M; Oota H
Ann Hum Genet; 2021 Sep; 85(5):166-177. PubMed ID: 34013582
[TBL] [Abstract][Full Text] [Related]
27. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
28. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623
[TBL] [Abstract][Full Text] [Related]
29. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden.
Ohara M; Yoshimoto T; Okazaki S; Gon Y; Todo K; Sasaki T; Takasugi J; Ohara N; Ihara M; Mochizuki H
J Atheroscler Thromb; 2022 Nov; 29(11):1655-1662. PubMed ID: 34955493
[TBL] [Abstract][Full Text] [Related]
30. Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.
Zhang Q; Ge P; Ma Y; Zhang D; Wang R; Zhang Y; Wang S; Cao Y; Zhao M; Zhao J
J Child Neurol; 2019 Nov; 34(13):793-800. PubMed ID: 31290353
[TBL] [Abstract][Full Text] [Related]
31. Genetic analysis of
Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T
Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275
[No Abstract] [Full Text] [Related]
32. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
[TBL] [Abstract][Full Text] [Related]
33. Role of Ring Finger Protein 213 in Moyamoya Disease.
Ma YG; Zhang Q; Yu LB; Zhao JZ
Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
[TBL] [Abstract][Full Text] [Related]
34. Association between RNF213 c.14576G>A Variant (rs112735431) and Peripheral Pulmonary Artery Stenosis in Moyamoya Disease.
Ozaki D; Endo H; Tashiro R; Sugimura K; Tatebe S; Yasuda S; Tomata Y; Endo T; Tominaga K; Niizuma K; Fujimura M; Tominaga T
Cerebrovasc Dis; 2022; 51(3):282-287. PubMed ID: 34710878
[TBL] [Abstract][Full Text] [Related]
35. RNF213 vasculopathy manifested in various forms within a family: A case report.
Lim SS; Park S; Oh BH; Jung K; Bae JW; Bae DH
Medicine (Baltimore); 2023 Dec; 102(50):e36627. PubMed ID: 38115307
[TBL] [Abstract][Full Text] [Related]
36. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
Biochem Biophys Res Commun; 2013 Oct; 439(4):419-26. PubMed ID: 23994138
[TBL] [Abstract][Full Text] [Related]
37. Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature.
Strunk D; Bauer P; Keyvani K; Diehl RR; Veltkamp R; Berlit P; Meuth SG; Timmermann L; Schwitalla JC; Kraemer M
J Neurol; 2024 Jun; 271(6):3328-3339. PubMed ID: 38478032
[TBL] [Abstract][Full Text] [Related]
38. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.
Ma J; Liu Y; Ma L; Huang S; Li H; You C
Neurol India; 2013; 61(1):35-9. PubMed ID: 23466837
[TBL] [Abstract][Full Text] [Related]
39. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
